CAS 1393898-89-9

Formel: C34H34O8

InChl: InChI=1S/C34H34O8/c1-37-27-17-19-28(20-18-27)40-34-32(42-33(36)26-15-9-4-10-16-26)31(39-22-25-13-7-3-8-14-25)30(35)29(41-34)23-38-21-24-11-5-2-6-12-24/h2-20,29-32,34-35H,21-23H2,1H3

InChI Key: BTAGGJNAQHYZAF-UHFFFAOYSA-N

SMILES: COC1=CC=C(C=C1)OC2C(C(C(C(O2)COCC3=CC=CC=C3)O)OCC4=CC=CC=C4)OC(=O)C5=CC=CC=C5

4-Methoxyphenyl 2-O-Benzoyl-3,6-di-O-benzyl-β-D-glucopyranoside

CAS: 1393898-89-9

Formel: C₃₄H₃₄O₈

Reinheit: >95.0%(HPLC)

Farbe und Form: White to Light yellow powder to crystal

Molekulargewicht: 570.64

Ref: 3B-M2434

4-​Methoxyphenyl 2-​O-​Benzoyl-​3,​6-​di-​O-​benzyl-​β-​D-​glucopyranoside

Kontrolliertes Produkt

CAS: 1393898-89-9

Formel: C₃₄H₃₄O₈

Farbe und Form: Neat

Molekulargewicht: 570.629

Ref: TR-M871618

4-Methoxyphenyl 2-O-benzoyl-3,6-di-O-benzyl-b-D-glucopyranoside

CAS: 1393898-89-9

4-Methoxyphenyl 2-O-benzoyl-3,6-di-O-benzyl-b-D-glucopyranoside is a mutant that has been identified in patients with cirrhosis. This variant is characterized by a transition from G to T at nucleotide position 1 of the coding region, which encodes for methionine at amino acid position 5. The mutant allele was found to be present in 53% of patients who had undergone abdominal ultrasonography and had liver cancer. In laboratory tests, this mutant demonstrated increased sensitivity to azide and an increased susceptibility to hepatoma. This variant has also been shown to be associated with an increased risk of developing cancer.

Formel: C₃₄H₃₄O₈

Reinheit: Min. 95%

Molekulargewicht: 570.63 g/mol

Ref: 3D-MM60613